Structure Therapeutics Inc (GPCR) insider trading
Every open-market stock purchase and sale by Structure Therapeutics Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Xichen Lin (C-suite exec) and 1 other sold $829K in the last 90 days.
- Last insider buy: Ramy Farid (Director), $4.1M, 3 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $8.7M (10 sales). Last close $22.01 on Oct 21, 2026.
Recent GPCR insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 21, 2026 | Crespo Blas Coll (C-suite exec) | Sold | $145K |
| Sep 21, 2026 | Crespo Blas Coll (C-suite exec) | Bought (not open market) | — |
| Sep 21, 2026 | Crespo Blas Coll (C-suite exec) | Sold (not open market) | — |
| Sep 18, 2026 | Crespo Blas Coll (C-suite exec) | Sold (not open market) | $124K |
| Sep 1, 2026 | Xichen Lin (C-suite exec) | Sold | $214K |
| Sep 1, 2026 | Xichen Lin (C-suite exec) | Sold | $59.6K |
| Sep 1, 2026 | Xichen Lin (C-suite exec) | Sold | $4.8K |
| Sep 1, 2026 | Xichen Lin (C-suite exec) | Sold (not open market) | — |
| Sep 1, 2026 | Xichen Lin (C-suite exec) | Bought (not open market) | — |
| Sep 1, 2026 | Xichen Lin (C-suite exec) | Bought (not open market) | — |
| Aug 18, 2026 | Xichen Lin (C-suite exec) | Sold | $160K |
| Aug 18, 2026 | Xichen Lin (C-suite exec) | Sold | $28.1K |
| Aug 18, 2026 | Xichen Lin (C-suite exec) | Sold | $22K |
| Aug 18, 2026 | Xichen Lin (C-suite exec) | Bought (not open market) | — |
| Aug 18, 2026 | Xichen Lin (C-suite exec) | Sold (not open market) | — |
| Aug 18, 2026 | Xichen Lin (C-suite exec) | Bought (not open market) | — |
| Aug 6, 2026 | John Joseph Berrios (C-suite exec) | Bought (not open market) | — |
| Aug 6, 2026 | John Joseph Berrios (C-suite exec) | Bought (not open market) | — |
| Aug 4, 2026 | Xichen Lin (C-suite exec) | Sold | $153K |
| Aug 4, 2026 | Xichen Lin (C-suite exec) | Sold | $42K |
| Aug 4, 2026 | Xichen Lin (C-suite exec) | Sold (not open market) | — |
| Aug 4, 2026 | Xichen Lin (C-suite exec) | Bought (not open market) | — |
| Aug 4, 2026 | Xichen Lin (C-suite exec) | Bought (not open market) | — |
| Jul 22, 2026 | Fmr LLC (Insider) | Sold | $805K |
| Jul 22, 2026 | Fmr LLC (Insider) | Sold | $68.4K |
Who's trading GPCR
- Crespo Blas Coll, C-suite exec: sold $145K (1 sale), last Sep 21, 2026
- Xichen Lin, C-suite exec: sold $1.5M (11 sales), last Sep 1, 2026
- John Joseph Berrios, C-suite exec: other filings, last Aug 6, 2026
- Fmr LLC, Insider: sold $7.1M (22 sales), last Jul 22, 2026
- Ted W Love, Insider: other filings, last Jun 17, 2026
- Angus C. Russell, Insider: other filings, last Jun 17, 2026
- Sharon Tetlow, Insider: other filings, last Jun 17, 2026
- Daniel G Welch, Insider: other filings, last Jun 17, 2026
- Joanne Waldstreicher, Insider: other filings, last Jun 17, 2026
- Eric Dobmeier, Insider: other filings, last Jun 17, 2026
- Matthew Lang, COO: other filings, last Apr 15, 2026
- Jun Yoon, CFO: other filings, last Mar 19, 2026
- Ashley Hall, C-suite exec: other filings, last Mar 19, 2026
- Yingli Ma, CTO: other filings, last Mar 19, 2026
- Raymond C Stevens, CEO: other filings, last Mar 19, 2026
Get free alerts when an insider at Structure Therapeutics Inc files a new trade →